位置:首页 > 蛋白库 > CMAH_PONPY
CMAH_PONPY
ID   CMAH_PONPY              Reviewed;         585 AA.
AC   Q8MJC6; Q8MJC7; Q8WNM4;
DT   10-MAY-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   03-AUG-2022, entry version 85.
DE   RecName: Full=Cytidine monophosphate-N-acetylneuraminic acid hydroxylase;
DE            Short=CMP-N-acetylneuraminic acid hydroxylase;
DE            EC=1.14.18.2;
DE   AltName: Full=CMP-N-acetylneuraminate monooxygenase;
DE   AltName: Full=CMP-Neu5Ac hydroxylase;
DE   AltName: Full=CMP-NeuAc hydroxylase;
DE   Flags: Fragment;
GN   Name=CMAH;
OS   Pongo pygmaeus (Bornean orangutan).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Pongo.
OX   NCBI_TaxID=9600;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=12192086; DOI=10.1073/pnas.182257399;
RA   Chou H.-H., Hayakawa T., Diaz S., Krings M., Indriati E., Leakey M.,
RA   Paabo S., Satta Y., Takahata N., Varki A.;
RT   "Inactivation of CMP-N-acetylneuraminic acid hydroxylase occurred prior to
RT   brain expansion during human evolution.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:11736-11741(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 11-507.
RX   PubMed=11948213; DOI=10.1093/jhered/92.6.469;
RA   Stauffer R.L., Walker A., Ryder O.A., Lyons-Weiler M., Hedges S.B.;
RT   "Human and ape molecular clocks and constraints on paleontological
RT   hypotheses.";
RL   J. Hered. 92:469-474(2001).
CC   -!- FUNCTION: Sialic acids are components of carbohydrate chains of
CC       glycoconjugates and are involved in cell-cell recognition and cell-
CC       pathogen interactions. Catalyzes the conversion of CMP-N-
CC       acetylneuraminic acid (CMP-Neu5Ac) into its hydroxylated derivative
CC       CMP-N-glycolylneuraminic acid (CMP-Neu5Gc), a sialic acid abundantly
CC       expressed at the surface of many cells. {ECO:0000250|UniProtKB:Q61419}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=CMP-N-acetyl-beta-neuraminate + 2 Fe(II)-[cytochrome b5] + 2
CC         H(+) + O2 = CMP-N-glycoloyl-beta-neuraminate + 2 Fe(III)-[cytochrome
CC         b5] + H2O; Xref=Rhea:RHEA:16145, Rhea:RHEA-COMP:10438, Rhea:RHEA-
CC         COMP:10439, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:29033, ChEBI:CHEBI:29034, ChEBI:CHEBI:57812,
CC         ChEBI:CHEBI:58376; EC=1.14.18.2;
CC   -!- COFACTOR:
CC       Name=[2Fe-2S] cluster; Xref=ChEBI:CHEBI:190135;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00628};
CC       Note=Binds 1 [2Fe-2S] cluster per subunit. {ECO:0000255|PROSITE-
CC       ProRule:PRU00628};
CC   -!- PATHWAY: Amino-sugar metabolism; N-acetylneuraminate metabolism.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the CMP-Neu5Ac hydroxylase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF494224; AAN05319.1; -; mRNA.
DR   EMBL; AF494225; AAN05320.1; -; mRNA.
DR   EMBL; AF354634; AAL56238.1; -; mRNA.
DR   AlphaFoldDB; Q8MJC6; -.
DR   UniPathway; UPA00628; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0051537; F:2 iron, 2 sulfur cluster binding; IEA:UniProtKB-KW.
DR   GO; GO:0030338; F:CMP-N-acetylneuraminate monooxygenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006054; P:N-acetylneuraminate metabolic process; IEA:UniProtKB-UniPathway.
DR   CDD; cd03473; Rieske_CMP_Neu5Ac_hydrolase_N; 1.
DR   Gene3D; 2.102.10.10; -; 1.
DR   Gene3D; 3.60.15.10; -; 1.
DR   InterPro; IPR037339; CMP-Neu5Ac_hydroxylase_Rieske.
DR   InterPro; IPR027033; Cnh.
DR   InterPro; IPR036866; RibonucZ/Hydroxyglut_hydro.
DR   InterPro; IPR017941; Rieske_2Fe-2S.
DR   InterPro; IPR036922; Rieske_2Fe-2S_sf.
DR   PANTHER; PTHR46522; PTHR46522; 1.
DR   Pfam; PF00355; Rieske; 1.
DR   SUPFAM; SSF50022; SSF50022; 1.
DR   SUPFAM; SSF56281; SSF56281; 1.
DR   PROSITE; PS51296; RIESKE; 1.
PE   2: Evidence at transcript level;
KW   2Fe-2S; Cytoplasm; Electron transport; Iron; Iron-sulfur; Metal-binding;
KW   Oxidoreductase; Transport.
FT   CHAIN           <1..585
FT                   /note="Cytidine monophosphate-N-acetylneuraminic acid
FT                   hydroxylase"
FT                   /id="PRO_0000127806"
FT   DOMAIN          9..107
FT                   /note="Rieske"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00628"
FT   BINDING         49
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00628"
FT   BINDING         51
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00628"
FT   BINDING         70
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00628"
FT   BINDING         73
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00628"
FT   CONFLICT        39
FT                   /note="K -> N (in Ref. 2; AAL56238)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        503..507
FT                   /note="REHPY -> ARTSL (in Ref. 2)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        560
FT                   /note="M -> T (in Ref. 1; AAN05319)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        583
FT                   /note="T -> K (in Ref. 1; AAN05319)"
FT                   /evidence="ECO:0000305"
FT   NON_TER         1
SQ   SEQUENCE   585 AA;  68018 MW;  3358E9D397225AA6 CRC64;
     QTTEILLCLS PVEVANLKEG INFFRNKSTG KDYILYKNKS RLRACKNMCK HQGGLFIKDI
     EDLAGRSVRC TKHNWKLDVS TMKYINPPES FCQDELVVEM DENNRLLLLE LNPPNPWDLQ
     PRSPEELAFG EVQITYLTHA CMDLKLGDKR MVFDPWLIGP AFARGWWLLH EPPSDWLERL
     CQADLIYISH LHSDHLSYPT LKKLAGRRPD IPIYVGNTER PVFWNLNQSG VQLTNINIVP
     FGIWQQVDKN LRFMILMDGV HPEMDTCIIV EYKGHKILNT VDCTRPNGGR LPMKVALMMS
     DFAGGASGFP MTFSGGKFTE EWKAQFIKTE RKKLLNYKAQ LVKNLQPRIY CPFAGYFVES
     HPSDKYIKET NTKNDPNELN NLIKKNSDVI TWTPRPGATL DLARMLKDPT DSKGIVEPPE
     GTKIYKDSWD FEPYLEILNA AVGDEIFLHS SWIKEYFTWA GFKDYNLVVR MIETDEDFNP
     FPGGYDYLVD FLDLSFPKER PQREHPYEEI HSRVDVIRHV VKNGLLWDEL YIGFQTRLQR
     DPDIYHHLFW NHFQIKLPLM PPNWKSFLMC CEQNEPGILQ ECTTT
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024